The $16.2 Billion Humanoid Robot Boom: Inside 2026's Record-Shattering Investment Wave

The humanoid robotics sector is experiencing an investment boom in 2026, with record-breaking funding totals, the emergence of major new players like Ant Group's Robbyant, dedicated ETF products for retail exposure, and ongoing regulatory scrutiny from the U.S. government. This article provides a comprehensive breakdown of the key developments.

Investment & Funding Totals

The year 2026 is shaping up to be a record-breaker for robotics investment broadly. By June 22, robotics startups had raised roughly $18.8 billion globally, already exceeding the total for all of 2025 . In China alone, robotics companies raised $5.6 billion across 176 deals by mid-May .

Within the humanoid segment, the momentum is even more pronounced. The humanoid segment raised a record $13.8 billion in 2025 (up from $7.8 billion in 2024), and the pace in 2026 has already surpassed that . Tracking databases show $16.2 billion in total tracked humanoid funding from 2024 through mid-2026 .

A key trend is the dominance of mega-rounds. Rounds above $50 million accounted for approximately 92% of year-to-date 2026 deals, up from 50% in 2024 . The median round size in early 2026 was about $200 million .

Leading Countries & Companies

China and the United States dominate the landscape, with China leading by deal count. By mid-2026, 10 of the 15 largest humanoid rounds globally went to Chinese startups . China also leads in production, with 10 robot models (38% of tracked robots), followed by the U.S. with 9 (35%) .

Top Humanoid Robotics Companies by Total Disclosed Funding (All-Time) :

Rank	Company	Country	Total Funding
1	UBTECH Robotics	China	$2.3 billion
2	Figure AI	USA	$1.7 billion
3	NEURA Robotics	Germany	$1.6 billion
4	Galbot	China	$986 million
5	Apptronik	USA	$935 million
6	Boston Dynamics	USA	$880 million
7	Unitree Robotics	China	$843 million

Tesla's Optimus program is tracked separately, with an estimated $20+ billion in dedicated capex (2025–2026) and an implied standalone valuation of $150 billion+ .

Largest Funding Rounds of 2026

The largest single humanoid round of 2026 went to a European company:

1. NEURA Robotics (Germany) — Series C of up to $1.4 billion (closed June 2026) at a ~$7 billion valuation, backed by Tether, Qualcomm, Amazon, and Nvidia .
2. AI² Robotics — ~$735 million
3. Apptronik (USA) — $520 million Series A (Feb 2026), backed by Google, Mercedes-Benz, ARK Invest
4. Rhoda AI (USA) — $450 million Series A
5. Agility Robotics (USA) — $620+ million via SPAC / proposed public listing (June 2026), with Foxconn and Churchill Capital
6. RobotEra (China) — ~$280 million strategic follow-on (April 2026) at ~$1.8 billion valuation
7. Physical Intelligence (π) (USA) — $1 billion Series C (rumored/in talks)
8. Humanoid (UK) — $152 million Series A (July 2026) at $1.35 billion post-money valuation, Europe's first pure-play humanoid unicorn

Ant Group's Robbyant — A New Major Entrant

Ant Group has aggressively entered the humanoid robotics space through its subsidiary Robbyant (formally Shanghai Ant Lingbo Technology Co., Ltd.). Established in December 2024 with RMB 100 million in registered capital, Robbyant is Ant Group's wholly owned embodied AI and robotics company .

Robbyant unveiled its first humanoid robot, the R1, in September 2025 — a wheeled humanoid priced at approximately $55,000, designed for hospitality, medical support, museums, and kitchens . In 2026, Robbyant released LingBot-VLA 2.0 (an open-source vision-language-action model, July 2026) and LingBot-VA 2.0 (the industry's first embodied-native video-action world model) .

Ant Group has made 12 investments in humanoid robotics companies in 18 months, most recently leading a 500 million yuan (~$70 million) round for Zeroth Robotics . Robbyant positions itself as a direct competitor to Tesla's Optimus, leveraging Ant Group's AI and fintech ecosystem .

ETF Investment Options for Broader Exposure

Several ETFs now offer diversified exposure to humanoid robotics, ranging from pure-play humanoid funds to broader robotics and automation funds :

ETF	Ticker	Focus	Expense Ratio	Notes
KraneShares Global Humanoid Robotics & Physical AI ETF	KOID	Humanoid robotics & physical AI pure play	~0.68%	First dedicated humanoid robotics ETF, 50 holdings
Roundhill Humanoid Robotics ETF	HUMN	Humanoid & embodied AI	~0.75%	Options-tradable
Themes Humanoid Robotics ETF	BOTT	Humanoid robotics	Varies	Targets humanoid-specific value chain
Global X Robotics & AI ETF	BOTZ	Broader robotics & AI	0.68%	Established, largest robotics-focused ETF
ROBO Global Robotics & Automation ETF	ROBO	Robotics & automation	Varies	Broader exposure
iShares Automation & Robotics UCITS ETF	Various	Global automation & robotics	~0.40%	EU-domiciled option

Analysts recommend KOID, BOTT, and HUMN for concentrated humanoid exposure, while BOTZ and ROBO offer broader robotics diversification .

U.S. Government Regulatory Actions

Available search results do not provide sufficient evidence to detail specific 2026 U.S. regulatory actions directly targeting humanoid robotics. The broader context includes existing export controls on advanced AI and semiconductor technology (imposed by the Bureau of Industry and Security since October 2022 and expanded through 2024–2025) that affect the chips and AI models used in humanoid robots, especially for Chinese companies. Ongoing CFIUS reviews of foreign investments in U.S. robotics and AI startups also apply. Proposed bills in Congress around AI safety, embodied AI liability, and national security reviews of advanced robotics have been discussed, but no specific finalized humanoid-focused regulation was captured in the available search results.

Note: The U.S. export control framework for advanced semiconductors, which power humanoid robots, continues to tighten. Any new specific 2026 actions targeting humanoid robotics hardware or software would require a dedicated search to confirm.